TY - JOUR
T1 - Organization-based performance measures of cancer care quality
T2 - Core measure development for breast cancer in Taiwan
AU - Chung, K. P.
AU - Lai, M. S.
AU - Cheng, S. H.
AU - Tang, S. T.
AU - Huang, C. C.
AU - Cheng, A. L.
AU - Hsieh, P. C.
PY - 2008/1
Y1 - 2008/1
N2 - The purpose of the study was to develop organization-based core performance measures (CPMs) for breast cancer patients treated in hospitals that participated in cancer quality improvement programmes in Taiwan. CPMs were developed in three stages that included a preparation, a consensus building stage, and two stages of stakeholder feedback. Three criteria and seven subcriteria were applied in the development process. Indicators listed in a Delphi questionnaire were based on a literature search, indicators developed by relevant institutions and discussion by authors. Each indicator needed to meet inclusion criteria as a final indicator. Evidence-based guidelines, expert opinions from panel group, 27 hospitals and empirical data were all applied to develop and revise the core measures. Fifteen out of 28 indicators were selected and modified after the three stages. There were two pre-treatment indicators for screening and diagnosis, nine treatment-related indicators, and four monitoring-related indicators. Six indicators were supported by evidence level I, and four indicators by level II evidence. The CPMs for breast cancer can be developed systematically and be applied for internal quality improvement and external surveillance. Our experience can be extended to other cancer sites and adapted to link with pay for performance or certification program in cancer care.
AB - The purpose of the study was to develop organization-based core performance measures (CPMs) for breast cancer patients treated in hospitals that participated in cancer quality improvement programmes in Taiwan. CPMs were developed in three stages that included a preparation, a consensus building stage, and two stages of stakeholder feedback. Three criteria and seven subcriteria were applied in the development process. Indicators listed in a Delphi questionnaire were based on a literature search, indicators developed by relevant institutions and discussion by authors. Each indicator needed to meet inclusion criteria as a final indicator. Evidence-based guidelines, expert opinions from panel group, 27 hospitals and empirical data were all applied to develop and revise the core measures. Fifteen out of 28 indicators were selected and modified after the three stages. There were two pre-treatment indicators for screening and diagnosis, nine treatment-related indicators, and four monitoring-related indicators. Six indicators were supported by evidence level I, and four indicators by level II evidence. The CPMs for breast cancer can be developed systematically and be applied for internal quality improvement and external surveillance. Our experience can be extended to other cancer sites and adapted to link with pay for performance or certification program in cancer care.
KW - Breast cancer
KW - Cancer quality improvement programme
KW - Core performance measures
KW - Organization-based measures
KW - The modified Delphi technique
UR - http://www.scopus.com/inward/record.url?scp=37549042034&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2354.2007.00796.x
DO - 10.1111/j.1365-2354.2007.00796.x
M3 - 文章
C2 - 18181886
AN - SCOPUS:37549042034
SN - 0961-5423
VL - 17
SP - 5
EP - 18
JO - European Journal of Cancer Care
JF - European Journal of Cancer Care
IS - 1
ER -
